{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_057173.4:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_057173.4",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "p.G2019S (LRRK2) variant"
        },
        {
          "HGVS": "NM_057173.4:c.4322G>C",
          "cDNA Change": {
            "transcript": "NM_057173.4",
            "ref": "G",
            "alt": "C",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "p.R1441C (LRRK2) variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005255"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with LRRK2 variants (p.G2019S and p.R1441C)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057173.4:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of Î±-synuclein in p.G2019S-expressing cells compared to wild-type."
        },
        {
          "Variant": "NM_057173.4:c.4322G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced kinase activity in p.R1441C-expressing cells compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 10% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels deviating by more than 20% from wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells were treated with LRRK2 variants (p.G2019S and p.R1441C)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057173.4:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Significant increase in cell death (30% reduction in viability) for p.G2019S compared to wild-type."
        },
        {
          "Variant": "NM_057173.4:c.4322G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Moderate increase in cell death (15% reduction in viability) for p.R1441C compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "No positive control was explicitly mentioned."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability above 80%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability below 60%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Primary neurons",
        "Material Name": "Mouse dopaminergic neurons",
        "Description": "Mouse dopaminergic neurons were transfected with LRRK2 variants (p.G2019S and p.R1441C)."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_057173.4:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Altered localization of LRRK2 to lysosomes in p.G2019S-expressing neurons compared to wild-type."
        },
        {
          "Variant": "NM_057173.4:c.4322G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced LRRK2 localization to mitochondria in p.R1441C-expressing neurons compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was imaged in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "No positive control was explicitly mentioned."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated neurons were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LRRK2 localization to lysosomes or mitochondria within 10% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "LRRK2 localization deviating by more than 20% from wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}